Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernadette Mannaerts

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Frontiers in Endocrinology|November 7, 2022
Dose-dependent stimulation of human follicular steroidogenesis by a novel rhCG during ovarian stimulation with fixed rFSH dosingJane Alrø Bøtkjær, Stine Gry Kristensen, Hanna Ørnes Olesen, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 8, 2021
First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for reconstitutionDaniël M Jonker, Manuela Koch, Per Larsson, et al.
Reproductive Biology and Endocrinology : RB&E|September 14, 2013
Clinical impact of LH rises prior to and during ganirelix treatment started on day 5 or on day 6 of ovarian stimulationJohn L Frattarelli, Torbjörn Hillensjö, Frank J Broekmans, et al.
Human Reproduction (Oxford, England)|May 31, 2011
Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicityRobert J Norman, Fernando Zegers-Hochschild, Bruno S Salle, et al.
Reproductive Biomedicine Online|December 31, 2018
Follitropin delta in repeated ovarian stimulation for IVF: a controlled, assessor-blind Phase 3 safety trialErnesto Bosch, Jon Havelock, Fernando Sánchez Martin, et al.
Reproductive Biology and Endocrinology : RB&E|May 16, 2023
Live birth rates following individualized dosing algorithm of follitropin delta in a long GnRH agonist protocolManuel Fernández Sánchez, Per Larsson, Marcos Ferrando Serrano, et al.
Fertility and Sterility|May 25, 2015
Large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilizationRobert Boostanfar, Bruce Shapiro, Michael Levy, et al.
Human Reproduction (Oxford, England)|April 22, 2022
A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocolManuel Fernández Sánchez, Hana Višnová, Per Larsson, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|March 21, 2012
A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy ratesJie Qiao, Guangxiu Lu, H W Zhang, et al.
Human Reproduction (Oxford, England)|June 28, 2021
A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF/ICSI patientsJie Qiao, Yunshan Zhang, Xiaoyan Liang, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Endocrinology|November 7, 2022
Dose-dependent stimulation of human follicular steroidogenesis by a novel rhCG during ovarian stimulation with fixed rFSH dosingJane Alrø Bøtkjær, Stine Gry Kristensen, Hanna Ørnes Olesen, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 8, 2021
First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for reconstitutionDaniël M Jonker, Manuela Koch, Per Larsson, et al.
Reproductive Biology and Endocrinology : RB&E|September 14, 2013
Clinical impact of LH rises prior to and during ganirelix treatment started on day 5 or on day 6 of ovarian stimulationJohn L Frattarelli, Torbjörn Hillensjö, Frank J Broekmans, et al.
Human Reproduction (Oxford, England)|May 31, 2011
Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicityRobert J Norman, Fernando Zegers-Hochschild, Bruno S Salle, et al.
Reproductive Biomedicine Online|December 31, 2018
Follitropin delta in repeated ovarian stimulation for IVF: a controlled, assessor-blind Phase 3 safety trialErnesto Bosch, Jon Havelock, Fernando Sánchez Martin, et al.
Reproductive Biology and Endocrinology : RB&E|May 16, 2023
Live birth rates following individualized dosing algorithm of follitropin delta in a long GnRH agonist protocolManuel Fernández Sánchez, Per Larsson, Marcos Ferrando Serrano, et al.
Fertility and Sterility|May 25, 2015
Large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilizationRobert Boostanfar, Bruce Shapiro, Michael Levy, et al.
Human Reproduction (Oxford, England)|April 22, 2022
A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocolManuel Fernández Sánchez, Hana Višnová, Per Larsson, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|March 21, 2012
A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy ratesJie Qiao, Guangxiu Lu, H W Zhang, et al.
Human Reproduction (Oxford, England)|June 28, 2021
A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF/ICSI patientsJie Qiao, Yunshan Zhang, Xiaoyan Liang, et al.
Pageof 4